Summary: Founder and Executive Director of MAPS Rick Doblin discusses a new study that supports the psychedelic MDMA as treatment for PTSD on ‘Kennedy.’ Originally appearing here (Archived) …
Summary: In the Spring 2022 issue of the Harvard Medicinemagazine, Allison Eck weaves through the challenges of Harvard’s history with psychedelics to explore the current progress of interdisciplinary …
Summary: MAPS-sponsored researcher Rachel Yehuda, Ph.D., of Icahn School of Medicine at Mount Sinai joins PBS’ Healthy Minds with Dr. Jeffrey Borenstein of the Brain & Behavior Research Foundation …
Summary: Forbes publishes an exclusive report on the $500,000 donation to MAPS from atai Impact, the philanthropic arm of Berlin-based atai Life Sciences (NASDAQ: ATAI). Originally appearing here (Archived)
CBS News airs an investigative report about treating PTSD with MDMA-assisted therapy on a new episode of CBS Sunday Morning. In a series of interviews with David Martin of CBS, former Marine Scott Ostrom …
Summary: The New York Times publishes an investigative article exploring the impact of PTSD and moral injury in Veterans, highlighting published data from MAPS-sponsored clinical trials of MDMA-assisted …
The New York Times publishes an in-depth report on Veterans advancing the field of psychedelic medicine, highlighting personal experiences, public advocacy, drug policy reform efforts, and new initiatives …
You’re having a VR program that’s supposed to somehow remind you of your own inner imagery, so it will be not as precise as your own imagination. -Rick Doblin Originally appearing here (Archived)
In its capacityas afinancial news and media outlet,Benzinga has added six new members to its Psychedelics Advisory Council. The new members includerenowned authorAmanda Siebert; Revitalist Lifestyle & …
Green Bay Packers quarterback Aaron Rodgers and prominent podcaster Tim Ferriss are among thedozens of speakersmaking a trip to Denver this summer for a conference dedicated to all things psychedelics. …
“Australia’s policy change is one that every country should consider: suffering people, regardless of nationality, need more opportunities to access novel treatments,” MAPS founder and director Dr. …
